Company

Oculeve, Inc.

Oculeve develops therapies for dry eye conditions using proprietary technology, based in South San Francisco.

About

Oculeve, Inc. develops treatments for dry eye conditions using its proprietary technology. Founded in 2011 and based in South San Francisco, US, the company was acquired by Allergan Inc. in July 2015 for USD 125 mn. Its stage is recorded as Series B.

2Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in